NCT01492621View on ClinicalTrials.gov

Effect of Antidepressants on White Matter Structure

PHASE4UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Major Depression
Interventions
DRUG

Desvenlafaxine

Desvenlafaxine 50mg from week 1-8. At week 8 optional increase to 100mg if remission has not been attained.

Trial Locations (1)

H1N3V2

RECRUITING

Centre de Recherche Fernand-Seguin, Montreal

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal

OTHER